Role of Tyr356(7.43) and Ser190(4.57) in antagonist binding in the rat β1-adrenergic receptor

Journal of Medicinal Chemistry

Volumn 49, Issue 12, 2006, Pages 3467-3477

  Rezmann Vitti, Linda A ^a   Nero, Tracy L ^a   Jackman, Graham P ^a   Machida, Curtis A ^b   Duke, Brian J ^c   Louis, William J ^a   Louis, Simon N S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; DOPAMINE 2 RECEPTOR; MUSCARINIC M1 RECEPTOR; PROPANOLAMINE DERIVATIVE; SERINE; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BINDING AFFINITY; BINDING SITE; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; HYDROPHOBICITY; MODEL; MOUSE; MUTANT; NONHUMAN; PHOTOAFFINITY LABELING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; WILD TYPE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CRICETULUS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PROPANOLAMINES; RATS; RECEPTORS, ADRENERGIC, BETA-1; SERINE; STEREOISOMERISM; TRANSFECTION; TYROSINE;

EID: 33745172476     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050624l     Document Type: Article

References (54)

1. Gether, U. Uncovering molecular mechanisms involved in activation of G protein coupled receptors. Endocr. Rev. 2000, 21, 90-113.
2. 2-adrenergic receptor. Mol. Pharmacol. 2002, 62, 1431-1437.
3. Karnik, S. S.; Gogonea, C.; Patil, S.; Saad, Y.; Takezako, T. Activation of G-protein-coupled receptors: A common molecular mechanism. Trends Endocr. Metab. 2003, 14, 431-437.
4. 2- adrenergic receptor results in structurally distinct activated receptor conformations. Biochemistry 2002, 41, 6045-6053.
5. 2-adrenoceptor. Kinetic evidence for intermediate conformational states. J. Biol. Chem. 2004, 279, 686-691.
6. Dixon, R. A. F.; Sigal, I. S.; Strader, C. D. Structure-function analysis of the β-adrenergic receptor. Cold Spring Harbor Symp. Quant. Biol. 1988, 3, 487-497.
7. 1-selective binding in resting and active states. J. Pharmacol. Exp. Ther. 2002, 301, 51-58.
8. Strader, C. D.; Candalore, M. R.; Hill, W. S.; Dixon, R. A. F.; Sigal, I. S. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J. Biol. Chem. 1989, 264, 13572-13578.
9. 2-adrenergic receptor. J. Biol. Chem. 2000, 275, 37779-37788.
10. 2-adrenergic receptor. Br. J. Pharmacol. 2002, 135, 1715-1722.
11. Wieland, K.; Zuurmond, H. M.; Krasel, C.; Ijzerman, A. P.; Lohse, M. J. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 9276-9281.
12. Lewell, X. Q. A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. Drug Des. Discovery 1992, 9, 29-48.
13. Trumpp-Kallmeyer, S.; Hoflack, J.; Bruinvels, A.; Hibert, M. Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992, 35, 3448-3462.
14. 356(7.43). Biochem. Pharmacol. 2004, 68, 675-688.
15. 1-AR, the amino acid residues have been dually numbered according to the nomenclature of Ballesteros and Weinstein (Ballesteros, J. A.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 1995, 25, 366-428). In superscript they are numbered according to their position in the receptor sequence, and in parentheses they have been given a number corresponding to their relative position in the helix. In this universal numbering system, every amino acid number begins with the tm number, followed by a number that defines their position relative to the most conserved residue in that tm. The reference residue is assigned the number 50. To avoid confusion, amino acid residues in other receptors are numbered only using the universal numbering system.
16. 1A receptors. Mol. Pharmacol. 1992, 41, 695-698.
17. 2-adrenergic receptor. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 12322-12327.
18. 1Dβ T355N mutant receptors may involve formation of two hydrogen bonds to asparagine. Mol. Pharmacol. 1996, 49, 198-206.
19. 2 adrenergic receptor increases its affinity for a family of β receptor antagonists. J. Biol. Chem. 1991, 266, 15488-15492.
20. 1A receptor. Mol. Pharmacol. 1997, 51, 889-896.
21. 1B receptors. Eur. J. Pharmacol. 1993, 244, 77-87.
22. 2-adrenergic receptor modify ligand-binding specificity. Mol. Pharmacol. 1993, 44, 111-114.
23. Ijzerman, A. P.; Zuurmond, H. M. Molecular modelling of β-adrenoceptors. In Membrane Protein Models: Experiment, Theory and Speculation; Findlay, J. Ed.; BIOS Scientific Publishers: Oxford, 1996; pp 133-144.
24. 1A receptor: Agonist and antagonist binding sites. Drug Des. Discovery 1994, 11, 231-249.
25. 125Iodo]cyanopindolol binding. Eur. J. Med. Chem. 2004, 39, 625-631.
26. 1 muscarinic acetylcholine receptor are critical for ligand binding and the receptor activation switch. J. Biol. Chem. 2001, 276, 34098-34104.
27. 2 receptor: Accessibility in the binding-site crevice and position in the transmembrane bundle. Biochem. 2000, 39, 12190-12199.
28. Horn, F.; Vriend, G.; Cohen, F. E. Collecting and harvesting biological data: The GPCRDB and NucleaRDB information systems. Nucl. Acids Res. 2001, 29, 346-349.
29. 1-adrenoceptors. Eur. J. Med. Chem. 2002, 37, 111-125.
30. 1-specific antagonist. Eur. J Med. Chem. 2002, 37, 731-741.
31. Berthold, R.; Louis, W. J. 3-Aminopropoxyphenyl derivatives and pharmaceutical compositions containing them. US Patent 4425362, 1984.
32. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
33. 2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist. Biochem. J. 2001, 354, 485-491.
34. 1-adrenergic receptor antagonist binding. J. Biol. Chem. 2001, 276, 25366-25371.
35. 1-adrenergic receptor subtypes by molecular modeling. Life Sci. 2002, 71, 2531-2541.
36. Wong, S. K. F.; Claughter, C.; Ruoho, A. E.; Ross, E. M. The catecholamine binding site of the β-adrenergic receptors is formed by juxtaposed membrane spanning domains. J. Biol. Chem. 1988, 263, 7925-7928.
37. Fersht, A. R. Relationships between apparent binding energies measured in site-directed mutagenesis experiments and energetics of binding and catalysis. Biochemistry 1988, 27, 1577-1580.
38. Meyer, E. A.; Castellano, R. K.; Diederich, F. Interactions with Aromatic Rings in Chemical and Biological Recognition. Angew. Chem., Int. Ed. 2003, 42, 1210-1250.
39. Serrano, L.; Bycroft, M.; Fersht, A. R. Aromatic-aromatic interactions and protein stability. Investigation by double-mutant cycles. J. Mol. Biol. 1991, 218, 465-475.
40. Carlsson, P. A. E.; Brandstrom, A. E.; Lamm, B. R.; Ablad, B. A. H.; Carlsson, S. A. I.; Corrodi, H. R.; Ek, L. 1-(Alkylamino)-3-(p-alkoxyphenoxy)-2- propanols as β-blockers in heart diseases. German patent DE 2020864, 1970.
41. Lew, R.; Summers, R. J. Autoradiographic localisation of β-adrenoceptor subtypes in guinea-pig kidney. Br. J. Pharmacol. 1985, 85, 341-348.
42. 3-adrenergic receptor. Mol. Pharmacol. 1993, 44, 1094-1104.
43. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
44. McPherson, G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed. 1983, 17, 107-113.
45. Munson, P. J.; Rodbard, D. LIGAND: A versatile computerised approach for the characterisation of ligand binding systems. Anal. Biochem. 1980, 109, 220-239.
46. Analyse-it, General statistics software for Microsoft Excel, Analyse-It Software Ltd., PO Box 103, Leeds LS27 7WZ, England.
47. Sybyl 6.8/6,9/7.0, Tripos Inc., 1699 South Hanley Road, St. Louis, MO 63144, USA.
48. 14 two higher resolution bovine rhodopsin crystal structures have become available (1GZM, resolution 2.65 Å, and 1U19, resolution 2.2 Å), Superimposition of the model template, i.e., the A chain of 1F88, with either 1GZM or 1U19 via the backbone atoms indicates little variation between the backbone atoms of the three crystal structures (rms < 1.1 Å between 1F88 and either 1GZM or 1U19).
49. Mopac 6.00, as supplied within Sybyl 6.8/6.9/7.0.
50. (a) Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B 1988, 37, 785-789.
51. (b) Becke, A. D. Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys. 1993, 98, 5648-5652.
52. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Zakrzewski, V. G.; Montgomery, J. A., Jr.; Stratmann, R. E.; Burant, J. C.; Dapprich, S.; Millam, J. M.; Daniels, A. D.; Kudin, K. N.; Strain, M. C.; Farkas, O.; Tomasi, J.; Barone, V.; Cossi, M.; Cammi, R.; Mennucci, B.; Pomelli, C.; Adamo, C.; Clifford, S.; Ochterski, J.; Petersson, G. A.; Ayala, P. Y.; Cui, Q.; Morokuma, K.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Cioslowski, J.; Ortiz, J. V.; Baboul, A. G.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Gonzalez, C.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Andres, J. L.; Gonzalez, C.; Head-Gordon, M.; Replogle, E. S.; Pople, J. A. Gaussian 98, revision A.7, 1999. Gaussian Inc., 340 Quinnipiac St, Building 40, Wallingford, CT 06492.
53. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, revision C.02, 2004. Gaussian Inc., 340 Quinnipiac St, Building 40, Wallingford, CT 06492.
54. Frisch, M. J.; Head-Gordon, M.; Pople, J. A. Semi-direct algorithms for the MP2 energy and gradient. Chem. Phys. Lett. 1990, 166, 281-289.